Protagenic Therapeutics, Inc.
PTIX
$2.15
$0.000.00%
NASDAQ
| 06/30/2025 | 06/30/2024 | ||||
|---|---|---|---|---|---|
| Net Income | -5.06M | -324.40K | |||
| Total Depreciation and Amortization | 12.60K | -- | |||
| Total Amortization of Deferred Charges | 243.40K | -- | |||
| Total Other Non-Cash Items | 3.19M | -- | |||
| Change in Net Operating Assets | 448.30K | 77.90K | |||
| Cash from Operations | -1.17M | -246.40K | |||
| Capital Expenditure | -- | -- | |||
| Sale of Property, Plant, and Equipment | -- | -- | |||
| Cash Acquisitions | 943.20K | -- | |||
| Divestitures | -- | -- | |||
| Other Investing Activities | -- | -- | |||
| Cash from Investing | 943.20K | -- | |||
| Total Debt Issued | 77.80K | 1.22M | |||
| Total Debt Repaid | -- | -- | |||
| Issuance of Common Stock | 4.35M | 200.00 | |||
| Repurchase of Common Stock | -- | -- | |||
| Issuance of Preferred Stock | -- | -- | |||
| Repurchase of Preferred Stock | -- | -- | |||
| Total Dividends Paid | -- | -- | |||
| Other Financing Activities | -- | -260.00K | |||
| Cash from Financing | 4.42M | 962.60K | |||
| Foreign Exchange rate Adjustments | -117.20K | -4.20K | |||
| Miscellaneous Cash Flow Adjustments | -- | -- | |||
| Net Change in Cash | 4.08M | 712.00K | |||